Heart Failure Study: The Atlanta Cardiomyopathy Consortium
TACC
The Atlanta Cardiomyopathy Consortium
1 other identifier
observational
335
1 country
2
Brief Summary
Heart failure is a very common cause of hospital admission and there are half a million new cases diagnosed each year in the United States. While some important progress has been made over the last two decades for the treatment of heart failure, there still remains a critical need for further advances in our understanding of this disease in order to significantly improve patient outcomes. Large numbers of heart failure patients need to be studied over time to allow scientists to investigate those factors that influence the responses to therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2007
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 11, 2008
CompletedFirst Posted
Study publicly available on registry
January 23, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedResults Posted
Study results publicly available
January 1, 2014
CompletedNovember 2, 2015
August 1, 2015
5.6 years
January 11, 2008
November 13, 2013
October 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death, Heart Transplant, Left Ventricular Assist Device Implantation
5 years
Secondary Outcomes (1)
Hospitalization
30 days
Eligibility Criteria
Cardiology and general medicine clinics; Inpatients from cardiology services
You may qualify if:
- Age: 18 years and over
- Sex: Both
- Ethnic Origin: All
- Diagnosis required to participate: Clinical diagnosis of systolic or diastolic heart failure
You may not qualify if:
- Congenital heart disease
- Previous heart transplantation
- No primary infiltrative disease i.e. amyloidosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (2)
Center for Heart Failure at EUH Midtown, 4th Floor, 550 Peachtree Street
Atlanta, Georgia, 30308, United States
The Emory Clinic, Bldg A., 2nd Floor, 1365 Clifton Road, NE
Atlanta, Georgia, 30322, United States
Biospecimen
Blood for DNA/RNA/Proteomics analysis and Urine for proteomic analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Long baseline visit with several questionnaires to be completed made more difficult for the patients to be enrolled. Adverse Events data was not collected as part of this observational registry.
Results Point of Contact
- Title
- Dr. Javed Butler
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Javed Butler, MD, MPH
Emory University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
January 11, 2008
First Posted
January 23, 2008
Study Start
November 1, 2007
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
November 2, 2015
Results First Posted
January 1, 2014
Record last verified: 2015-08